Home > Drug Search >
  • company_query: Alkermes Pharma
  •   > 
Drug Filter
Category:
chemistry (77) biology (10)
Status:
Approved (4) NDA Filing (2) BLA Filing (1) Phase Ⅲ (12) Phase Ⅱ (34) Phase Ⅰ (33) IND Filing (1)
Clinical Stage:
Pending (10) Active (50) Discontinued (23)
Bio-Type:
Vaccine (1) Recombinant cytokines (1) Whole antibody (3) Fusion protein (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (3) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Advanced prostate cancer (1) Alcohol dependence (1) Allergic conjunctivitis (1) Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (2) Aspergillosis (1) Asthma (6) Atopic dermatitis (1) Basal cell carcinoma (BCC) (1) Bladder cancer (1) Breast cancer (5) Candidiasis (2) Castration-resistant prostate cancer (CRPC) (1) Chronic lymphocytic leukemia (CLL) (2) Chronic obstructive pulmonary disease (COPD) (3) Cognitive disorders (1) Community-acquired pneumonia (CAP) (1) Constipation (1) Cryptococcus neoformans (1) Dyslipidemia (1) Endometrial cancer (2) Gastric cancer (2) Gastric ulcer (2) Glioblastoma multiforme (1) HBV infection (1) HCV infection (4) Hepatocellular carcinoma (HCC) (3) Septicaemia (1) HIV infection (3) Hyperuricemia (1) Inflammatory bowel disease (1) Insomnia (1) Invasive aspergillosis (1) Leukemia (2) Lymphoma (6) Mantle cell lymphoma (MCL) (2) Medullary thyroid cancer (MTC) (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (8) Non-Hodgkin’s lymphoma (NHL) (2) Osteoporosis (1) Ovarian cancer (3) Pancreatic cancer (1) Parkinson's disease (PD) (1) Postherpetic neuralgia (PHN) (1) Prostate cancer (3) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Small cell lung cancer (SCLC) (2) Solid tumours (15) Rotavirus infection (1) Stable plaque psoriasis (1) Ulcerative colitis (1) Urinary incontinence (1) Head and neck cancer (2) Bone cancer (1) Hodgkin lymphoma (1) Colorectal cancer (3) Fungal infection (1) Spondyloarthritis (1) Invasive fungal infection (1) Serious infections caused by Fusarium spp. (1) Dental infection (1) Gynecologic infection (1) Pain (1) Methicillin-resistant staphylococcus aureus infections (1) Malignant glioma (1) Diabetic foot infections of the skin and soft tissue (1) Cervical carcinoma (2) Tibial fractures (1) Gram-positive bacterial infection (1) Spondylolisthesis (1) Glioma (2) Refractory diffuse large B cell lymphoma (1) Pulmonary fibrosis (1) Brain cancer (1) Drug-induced dyskinesia (1) Adrenocortical carcinoma (1) Liver cancer (2) Neurological disease (1) hematological malignancies (1) Agitation in patients with Alzheimer's disease (1) plasmodium falciparum malaria (1) Blood coagulation disorders (1) Hypersensitivity (1)
Country:
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top